Business Context and Reporting Period
This Form 8-K Current Report was filed by MYOMO, INC. on May 13, 2026, covering events occurring on May 9, 2026. The filing primarily addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel appointments and related disclosures.
Material Changes
- Board Appointment: The Board appointed Joseph M. Manko Jr. as a Class I director, effective May 9, 2026.
- Director Background: Mr. Manko is the Senior Principal of Horton Capital Management LLC, a significant shareholder in the Company, and brings extensive experience in corporate finance, private equity, and the med-tech/bio-pharmaceutical sectors.
- Term Details: His term will expire at the 2027 annual meeting of shareholders, at which time he will stand for election.
Guidance, Outlook, and Compensation
The filing provides no financial guidance, outlook, or management commentary regarding business operations. However, it discloses the compensation structure for non-employee directors:
- Cash Retainer: $60,000 annually.
- Equity Grant: Restricted stock units with a grant date fair value of $85,000 annually.
- Effective Date: Mr. Manko will be compensated under this structure beginning after the 2026 Annual Meeting of Stockholders.
- Committee Assignments: Mr. Manko has not been appointed to any Board committees at this time.
Investor Verification Checklist
- Verify Mr. Manko's current ownership stake in MYOMO, INC. as a "significant shareholder."
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.
- Confirm the date of the 2026 Annual Meeting of Stockholders to determine the exact start date of Mr. Manko's compensation.
- Check for any potential conflicts of interest given Mr. Manko's role as Chairman of Safeguard Scientifics, Inc. and director of KORU Medical Systems, Inc.